|
Benjamin Brenner(1), Eric F. Grabowski(2), Margaretta Hellgren(3), Gili Kenet(4), Patricia Massicotte(5), Marilyn Manco-Johnson(6), Prasad Mathew(7),Wolfgang Muntean(8), Nicole Schlegel(9), Ulrike Nowak-Göttl(10)
(1)Thrombosis and Hemostasis Unit, Rambam Medical Center, Haifa, Israel; (2)Cardiovascular Thrombosis Laboratory, Massachusetts General Hospital, Boston, USA; (3)Department of Obstetrics and Gynecology, Goteborg University and Sahlgrenska Univers
The implications of currently available data on the association of gestational vascular complications with thrombophilia are presented in this consensus report. Screening is recommended for women with the following previous complications: fetal loss including three or more first trimester loss, two or more sec ond trimester loss, or any stillbirth; early, severe or recurrent preeclampsia and severe intrauterine growth restriction. Maternal antithrombotic therapy is currently evaluated in women with thrombophilia and previous complications.